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Abstract
Nitric oxide (NO) has been implicated in the pathogenesis of septic shock. However, the role of
NO synthase 3 (NOS3) during sepsis remains incompletely understood. Here, we examined
impact of NOS3 deficiency on systemic inflammation and myocardial dysfunction during
peritonitis-induced polymicrobial sepsis. Severe polymicrobial sepsis was induced by colon
ascendens stent peritonitis (CASP) in wild-type (WT) and NOS3-deficient (NOS3KO) mice.
NOS3KO mice exhibited shorter survival time than did WT mice after CASP. NOS3 deficiency
worsened systemic inflammation assessed by the expression of inflammatory cytokines in the
lung, liver, and heart. CASP markedly increased the number of leukocyte infiltrating the liver and
heart in NOS3KO but not in WT mice. The exaggerated systemic inflammation in septic
NOS3KO mice was associated with more marked myocardial dysfunction than in WT mice 22h
after CASP. The detrimental effects of NOS3-deficiency on myocardial function after CASP
appear to be caused by impaired Ca2+ handling of cardiomyocytes. The impaired Ca2+ handling of
cardiomyocytes isolated from NOS3KO mice subjected to CASP was associated with depressed
mitochondrial ATP production, a determinant of the Ca2+ cycling capacity of sarcoplasmic
reticulum (SR) Ca2+-ATPase. The NOS3-deficiency-induced impairment of the ability of
mitochondria to produce ATP after CASP was at least in part attributable to reduction in
mitochondrial respiratory chain complex I activity. These observations suggest that NOS3 protects
against systemic inflammation and myocardial dysfunction after peritonitis-induced polymicrobial
sepsis in mice.
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INTRODUCTION
Septic shock is a complex syndrome that claims over 200,000 lives per year in the United
States (1). Although cytokines and nitric oxide (NO) have been implicated in the
pathogenesis of septic shock, the underlying mechanisms of organ dysfunction in sepsis
remain incompletely understood.
NO is synthesized by a family of enzymes referred as nitric oxide synthases (NOSs). There
are three known isoforms (NOS1, NOS2, and NOS3), that are obligate homodimers that
catalyze NADPH-dependent oxidation of L-arginine to NO and L-citrulline. NOS1
(neuronal NOS) is constitutively expressed in neuronal cells and cardiomyocytes. NOS2
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(inducible NOS) was first identified in macrophages but has since been detected in a wide
variety of cells, typically after exposure to lipopolysaccharide and/or cytokines. NOS3
(endothelial NOS) is constitutively expressed in the endothelial cells, endocardial cells, and
cardiomyocytes (2).
High levels of NO produced by NOS2 contribute to the systemic hypotension and organ
dysfunction associated with sepsis (3). However, despite the prominent role of NOS2 in
cardiovascular dysfunction of sepsis, a clinical trial using NOS inhibitors that are not
isoform-specific was associated with increased mortality in septic patients (4). Although
these observations indirectly suggest that NOS1 and/or NOS3 may have salutary effects on
cardiovascular function in sepsis, role of NOS3 in sepsis remains controversial. Studies
showed that NOS3 has no effects, pro-inflammatory, or anti-inflammatory effects in sepsis.
For example, Shesely and colleagues reported that NOS3 deficiency does not affect
mortality after endotoxin challenge (5). Recent studies showed that endotoxin-induced
systemic inflammation and hypotension were attenuated in NOS3KO mice compared with
WT mice (6), suggesting a pro-inflammatory role of NOS3 in sepsis. In contrast, NOS3-
overexpression in vascular endothelial cells attenuated endotoxin-induced lung injury and
mortality in mice (7). While these studies were performed using endotoxin challenge models
of sepsis, it has been suggested that a bolus injection of endotoxin is unlikely to reflect the
pathophysiology of clinical sepsis (8). Using a clinically-relevant polymicrobial sepsis
model, we recently reported that cardiomyocyte-specific overexpression of NOS3 prevents
myocardial dysfunction and death after sepsis (9). Nonetheless, role of endogenous levels of
NOS3 in septic shock remains to be defined.
The goal of the current study was to elucidate the impact of NOS3 on systemic inflammation
and myocardial dysfunction during a clinically-relevant polymicrobial sepsis. Based on our
previous study, we hypothesized that NOS3 has anti-inflammatory effects and protects
myocardial function during sepsis. To address this hypothesis, we examined the impact of
NOS3 deficiency on systemic inflammation and myocardial dysfunction in vivo and in
cardiomycytes isolated from mice subjected to peritonitis-induced polymicrobial sepsis.
Here, we report that NOS3 protects against systemic inflammation and myocardial
dysfunction during polymicrobial sepsis.
MATERIALS AND METHODS
Animals
After approval by the Massachusetts General Hospital Subcommittee on Research Animal
Care, all the animal experiments were performed in accordance with the guidelines of the
National Institutes of Health. Male WT (C57BL/6) and NOS3KO (Strain Name: B6.129P2-
Nos3tm1Unc/J) mice (5) backcrossed onto C57BL/6 background more than 10 generations
(2–6 months old, 20–30g) were purchased from the Jackson Laboratory (Bar Harbor, ME)
and given access to food and water ad libitum in our animal facility until the time of
experiments.
Sepsis model
Colon ascendens stent peritonitis (CASP) operation was performed to induce polymicrobial
sepsis as described previously (9, 10). Briefly, under anesthesia (80 mg/kg ketamine and 12
mg/kg xylazine ip) and after disinfection of the abdomen, a 14 gauge stent (14G Angiocath,
Becton Dickinson) was placed approximately 10 mm from the ileocecal valve through the
anti-mesenteric wall into the lumen of the ascending colon and then fixed with 7–0 stitches.
To ensure proper intraluminal positioning of the stent, stool was milked from the cecum into
the ascending colon toward the stent until a small drop of stool appeared. Fluid resuscitation
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of mice was performed by flushing 1.0 ml of sterile saline into the peritoneal cavity before
closure of the abdominal walls. Sham operation was performed in the same manner except
that only a stitch was made without placing a stent.
Survival analysis
Survival after surgery was assessed in age-matched male WT mice (n = 20) and NOS3KO
mice (n = 18). In accordance with the institutional animal care guidelines, a sepsis score
developed by Zantl and colleagues (10) was used with some modification to quantitate
severity of sepsis, that consists of assessment of 5 clinical parameters (Table 1). A score (0,
1, 2, or 3) was assigned to each item by an investigator blinded to the genotype of mice and
type of surgery. Lethal outcome was assumed when mice showed a sepsis score of more
than 9 points on a scale ranging from 0 to 15. Mice scoring 10 or more points were
euthanized. We chose 9 points based on our pilot studies in which mice that were assigned a
sepsis score of 9 or higher showed more than 90% mortality.
Measurements of gene expression
Total RNA was extracted from heart, lung, and liver tissues of WT and NOS3KO mice at
baseline (healthy control) and at 10h (heart, lung, and liver) and 22h (heart) after CASP
using the illustra RNA spin Mini kit (GE healthcare) and cDNA was synthesized using
MMLV-RT (Promega). TNF-α, IL-1β, IL-6, ICAM-1, NOS1, NOS2 and 18S ribosomal
RNA transcript levels were measured by real-time PCR using a Realplex 2 system
(Eppendorf, Inc.). Primers used were as follows: TNF-α (5′-
CAGCCTCTTCTCATTCCTGC-3′, 5′-GGTCTGGGCCATAGAACTGA-3′), IL-1β (5′-
GCAACTGTTCCTGAACTCAACT-3′, 5′-ATCTTTTGGGGTCCGTCAACT-3′), IL-6 (5′-
CCGGAGAGGAGACTTCACAGA-3′, 5′-CAGAATTGCCATTGCACAAC-3′), ICAM-1
(5′-TCCGCTGTGCTTTGAGAACT-3′, 5′-AGGGTGAGGTCCTTGCCTAC-3′), NOS1 (5′-
GCGGAGAACAGGATGAACTG-3′, 5′-AGGTCTCTGTCCACCTGGATT-3′), NOS2 (5′-
GTTCTCAGCCCAACAATACAAGA-3′, 5′-GTGGACGGGTCGATGTCAC-3′) and 18S
rRNA (5′-CGGCTACCACATCCAAGGAA-3′, 5′-GCTGGAATTACCGCGGCT-3′).
Changes in the relative gene expression normalized to levels of 18S rRNA were determined
using the relative CT method. The mean value of samples from control WT mice was set as
1.
Measurements of tissue leukocyte infiltration
Quantification of leukocyte recruitment to the heart and liver 22h after CASP was performed
on paraffin sections stained with anti-CD45 monoclonal antibodies (purified rat anti-mouse
CD45, BD Biosciences, San Jose, CA). The number of CD45+ cells was manually counted
by an investigator blinded to the genotype or treatment in three serial sections at mid-
papillary level of the heart and left lobe of the liver per mouse (n=3 for sham-operated and
n=5 for mice subjected to CASP for each genotype). The average number of leukocytes per
square millimeter of tissue area was reported.
Measurements of cardiac function
For measurement of cardiac function 22h after CASP or sham surgery, mice were
anesthetized by intraperitoneal injection with ketamine (100 mg/kg), fentanyl (50 μg/kg),
and pancuronium (2 mg/kg), intubated, and mechanically ventilated (fraction of inspired O2
= 1, 10 μl/g, 120 breaths/min). The chest was opened, and a pressure-volume conductance
catheter (model SPR-839, Millar Instruments, Houston, TX) was introduced through the
apex into the left ventricle (LV), as described previously (9).
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Measurement of contractility and intracellular Ca2+ concentration in isolated
cardiomyocytes
LV cardiomyocytes were enzymatically isolated from WT and NOS3KO mice 22 h after
CASP, as described previously (9). Cardiomyocytes isolated from healthy mice without
surgical intervention were used as controls. Cardiomyocytes were loaded with 1 μM fura-2/
AM (Invitrogen) and superfused with a buffer containing 137 mM NaCl, 5.4 mM KCl, 1.2
mM CaCl2, 0.5 mM MgCl2, 10 mM HEPES, 5.5 mM glucose and 0.5 mM probenecid, pH
7.4 at 32°C. Cardiomyocytes were paced at 2 Hz, and sarcomere length (SL) and fura-2
fluorescence were recorded simultaneously using the IonWizard video-edge detection and
fluorescence system (IonOptix, Milton MA). A subset of cardiomyocytes from each
genotype was utilized to calibrate the fura-2 fluorescence ratio to intracellular Ca2+
concentration values in situ.
Measurement of protein expression levels and phosphorylation of phospholamban
Protein extracts from LV tissue homogenates were microcentrifuged for 20 min at 20,000g.
Supernatant proteins (30 μg) were fractionated on 10 % SDS-PAGE gels and transferred to
nitrocellulose membranes. Membranes were blocked for 1h in 5 % non-fat milk and
incubated overnight with primary antibodies against sarcoplasmic reticulum (SR) Ca2+-
ATPase2a (Cell Signaling Technology Inc.), total phospholamban (PLN) (Affinity
Bioreagents, Inc.), PLN phosphorylated at Ser16 (Upstate Group LLC) and PLN
phosphorylated at Thr17 (Badrilla Ltd.). Bound antibodies were detected with a horseradish
peroxidase-linked antibody against mouse IgG (Promega Corp.) or rabbit IgG (Cell
Signaling Technology Inc.) and were visualized using chemiluminescence with ECL Plus
(Amersham Biosciences Corp.).
Isolation of heart mitochondria
Mouse heart mitochondria were isolated 22 h after CASP or sham operation by differential
centrifugation using the MITO-ISO1 kit (Sigma-Aldrich, Saint Louis, MO) following the
manufacturer’s instruction. A series of centrifugations were performed at 600 g and 6000 g.
The mitochondrial pellet was washed once and resuspended in a buffer containing 200 mM
mannitol, 70 mM sucrose and 10 mM HEPES (pH 7.4). Protein concentrations were
determined by the BCA assay (Pierce, Rockford, IL) using BSA as the standard.
Mitochondrial suspensions were kept on ice until use or frozen at − 80 °C for later
measurements of respiratory chain enzyme activity.
Measurements of mitochondrial permeability transition (MPT)
MPT pore opening was measured by monitoring the decrease in absorbance at 540 nm
associated with mitochondrial swelling (11). Mitochondrial suspensions were diluted to a
final concentration of 0.5 mg/ml in a buffer containing 200 mM mannitol, 70 mM sucrose,
10 mM HEPES and 5 mM succinate (pH 7.4). After 5 minutes of initial stabilization, 400
μM CaCl2 was added to induce MPT. The decrease in absorbance was monitored for 1000
seconds at room temperature with a spectrophotometer (BioRad, SmartSpec). The time in
seconds was calculated as t1/2 at which one-half of the absorbance change was observed and
used as an index of MPT.
Measurement of ATP production by mitochondria
The ability of mitochondria to produce ATP was determined with a luminescence-based
assay using the ATP Determination Kit (Invitrogen) according to the manufacturer’s
instruction. Aliquots of mitochondria were diluted to a final concentration of 0.002 mg/ml in
the reaction solution at room temperature. After a 3-minute stabilization period, 25 μM ADP
was added to initiate oxidative phosphorylation. Samples (100 μl each) were transferred to a
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96-well microplate and luminescence was monitored for 2 minutes at room temperature
using a Synergy 2 microplate reader (BioTek Instruments, Inc., Winooski, VT). The
standard curve was generated using known concentrations of ATP and was used to calculate
the rate of ATP production.
Complex I activity assay
Mitochondrial respiratory chain complex I activity was determined by
spectrophotometrically monitoring the oxidation of NADH in the presence of coenzyme Q1.
Aliquots of thawed mitochondria were diluted to a final protein concentration of 0.1 mg/ml
in the assay buffer containing 50 mM KCl, 10 mM Tris-HCl (pH 7.4), 1 mM EDTA, 2 mM
KCN, 10 μM antimycin A and 100 μM coenzyme Q1 in the presence or absence of 2 μM
rotenone. Samples (200 μl each) were transferred to a 96-well microplate and reactions were
initiated by addition of 100 μM NADH. The decrease in absorbance at 340 nm was
monitored at room temperature for 3 minutes using a Synergy 2 microplate reader. Complex
I activity was calculated from the difference between the NADH oxidation rate in the
presence and in the absence of rotenone, using an extinction coefficient of 6.22 mM−1·cm−1
at 340 nm (12).
Complex IV activity assay
Mitochondrial respiratory chain complex IV activity was determined by
spectrophotometrically monitoring the oxidation of reduced cytochrome c. Aliquots of
thawed mitochondria were diluted to a final protein concentration of 0.5 μg/ml in the assay
buffer containing 50 mM KH2PO4 (pH 7.2), 0.5 mM dodecyl maltoside. Reactions were
initiated by adding 50 μM of reduced cytochrome c (reduced with 1mM DTT). The decrease
in absorbance at 550 nm was monitored at room temperature using a spectrophotometer
(BioRad, SmartSpec). Complex IV activity was calculated from the initial rate of
cytochrome c oxidation, using an extinction coefficient of 18.5 mM−1·cm−1 at 550 nm (13).
Statistics
All data are presented as means ± SE. Data were analyzed by ANOVA using SigmaStat
statistical software package (Systat Software, Inc.). Analysis for gene expression levels was
performed after log transformation when appropriate. Student-Newman-Keuls post hoc test
was performed as required. Kaplan-Meier survival analysis was performed using the Gehan-
Breslow method.
RESULTS
NOS3 deficiency shortened survival time after CASP
All mice recovered from anesthesia uneventfully after CASP or sham operation. All mice
subjected to CASP developed clinical signs of sepsis including decreased mobility and
depressed level of alertness within 12 h after the operation, whereas mice subjected to sham
operation did not. While all mice died by 48h after CASP, NOS3KO mice exhibited a
shorter survival time than did WT mice (22±1 vs 31±3 h, P=0.023, Kaplan-Meier survival
analysis using the Gehan-Breslow method).
NOS3 deficiency worsens systemic inflammation after CASP
To elucidate the impact of NOS3 on systemic inflammation after CASP, we examined
expression levels of genes encoding inflammatory cytokines in the lung and liver at 10h and
in the heart at 10 and 22h after CASP. Levels of TNF-α, IL-1β, IL-6, ICAM-1, and NOS2
mRNA in the lung and liver were increased at 10h after CASP in both genotypes (Figure 1).
NOS3 deficiency markedly augmented the induction of IL-1β, IL-6, ICAM-1, and NOS2
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both in the lung and liver at 10h after CASP. Similarly, levels of IL-1β, IL-6, and ICAM-1
mRNA were increased in the heart at 10h after CASP in both genotypes (Figure 2). NOS3
deficiency markedly enhanced the induction of ICAM-1 at 10h and IL-1β and IL-6 in the
heart at 22h after CASP. Of note, in the heart, TNF-α was induced only after 22h after
CASP, and the expression of NOS1 and NOS2 did not significantly change after CASP.
These results suggest that NOS3 deficiency worsens systemic inflammation after CASP.
NOS3-deficiency increased leukocyte infiltration in heart and liver 22h after CASP
The number of CD45+ cells in the heart and liver did not differ between WT and NOS3KO
mice at baseline. In both heart and liver tissues, CASP markedly increased the number of
CD45+ cells in NOS3KO mice but not in WT mice (Figure 3). Of note, CD45+ cells were
found predominantly in the intravascular space in the liver but more CD45+ cells appeared
to be located in the extravascular compartment in the heart of NOS3KO mice after CASP.
NOS3 deficiency worsens cardiac dysfunction after CASP
Cardiac function parameters after sham operation were similar between both genotypes,
except that LV end-systolic pressure (LVESP) was higher in NOS3KO (Table 2). CASP
markedly depressed cardiac output (CO) only in NOS3KO but not in WT. CASP decreased
the maximum rate of developed LV pressure (dP/dtmax) and ejection fraction (EF) in both
genotypes, but the magnitude of reduction was greater in NOS3KO than in WT. Parameters
of load-independent LV contractility including dP/dtmax divided by instantaneous pressure
(dP/dtmax/IP) and end-systolic elastance (Ees) were markedly depressed in NOS3KO but not
in WT after CASP. Myocardial mechanical efficiency (estimated by the ratio of arterial
elastance to end-systolic elastance [Ea/Ees]) was impaired (increased ratio) in NOS3KO but
not in WT after CASP. As for diastolic function, CASP induced a greater increase of LV
end-diastolic pressure (LVEDP) in NOS3KO than in WT, and the time constant of
isovolumic relaxation (τ) was markedly prolonged after CASP in NOS3KO but not in WT
(Table 2). These results indicate that NOS3 deficiency impairs both systolic and diastolic
myocardial functions after CASP.
NOS3 deficiency worsens the contractile function and Ca2+ handling of cardiomyocytes
isolated from mice subjected to CASP
To further evaluate myocardial dysfunction after CASP in the absence of extracardiac
factors, we studied the contractile function and Ca2+ handling of isolated cardiomyocytes.
The yield of calcium-tolerant cardiomyocyte (40–50%) did not differ between WT and
NOS3KO with or without CASP. While CASP decreased sarcomere length (SL) shortening
and peak amplitude of intracellular Ca2+ transients (Δ [Ca2+]i) of isolated cardiomyocytes in
both genotypes, the magnitude of decrease was greater in NOS3KO than in WT (Figure 4
A–C). Although CASP prolonged the time constants for SL relengthening and [Ca2+]i decay
in both genotypes, the degree of prolongation was more marked in NOS3KO than in WT
(Figure 4D, 4E). CASP decreased SL shortening and peak [Ca2+]i in a parallel manner
between both genotypes (Figure 4F). These observations suggest that more marked
depression of cardiomyocyte function in NOS3KO mice is due to a greater impairment of
Ca2+ handling but not to altered myofilament sensitivity to calcium (Figure 4F).
NOS3 deficiency does not affect SR Ca2+-ATPase protein levels and phospholamban
phosphorylation
Sarcoplasmic reticulum (SR) Ca2+-ATPase activity is a major determinant of cardiomyocyte
calcium handling and is inhibited by phospholamban. Phosphorylation of phospholamban
releases the inhibition of SR Ca2+-ATPase activity. Protein expression levels of SR Ca2+-
ATPase did not differ between WT and NOS3KO with or without CASP (Figure 5A).
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Because we found a greater impairment of Ca2+ handling after CASP in NOS3KO heart,
impact of CASP on phosphorylation of phospholamban at Ser16 and Thr17 in cardiac tissue
extracts was examined. There was no difference in the fraction of PLN phosphorylated at
Ser16 or Thr17 between genotypes after CASP or sham operation (Figure 5B, 5C). These
results suggest that deleterious effects of NOS3 deficiency on SR Ca2+ handling after CASP
are not mediated by altered PLN phosphorylation.
CASP impairs cardiac mitochondrial integrity in NOS3KO mice
Ca2+ sequestration by SR Ca2+-ATPase is an energy consuming process that depends on
local energy levels primarily maintained by mitochondrial ATP production. To examine
whether or not mitochondrial dysfunction contributes to the sepsis-induced Ca2+
mishandling of cardiomyocytes in our model, we investigated cardiac mitochondrial
integrity and function 22h after CASP. CASP decreased t1/2 of the Ca2+-induced relative
absorbance change in NOS3KO but not in WT mitochondria. There was a trend towards a
faster occurrence of MPT in the mitochondria of NOS3KO than in WT after CASP (P =
0.094, WT CASP vs NOS3KO CASP; Figure 6A, 6B).
CASP impairs the ability of mitochondria to produce ATP
To further investigate the impact of sepsis on mitochondrial function, we studied
mitochondrial ATP production in cardiac mitochondria isolated from mice subjected to
CASP or sham operation. The yield of mitochondrial protein per tissue weight did not differ
between WT and NOS3KO with or without CASP. There was no difference in the ability to
produce ATP between mitochondria isolated from WT and NOS3KO after sham operation
(Figure 7A). In contrast, NOS3 deficiency markedly impaired the ability of isolated
mitochondria to produce ATP after CASP.
To elucidate the mechanism responsible for the CASP-induced inhibition of mitochondrial
ATP production, we measured the activities of mitochondrial respiratory chain complex I
and complex IV in a subgroup of mice 22 h after CASP or sham operation. Although
mitochondria isolated 22 h after sham operation showed comparable complex I activity in
both genotypes, it was lower in NOS3KO than in WT 22 h after CASP (Figure 7B). On the
other hand, complex IV activity did not change after CASP in both genotypes (Figure 7C).
These results indicate that NOS3 deficiency worsens the ability of mitochondria to produce
ATP after CASP at least in part via a greater inhibition of complex I, but not of complex IV
activity.
DISCUSSION
The current study revealed that NOS3 deficiency worsens sepsis-induced systemic
inflammation in a murine model of peritonitis-induced polymicrobial sepsis. The
pronounced systemic inflammation in NOS3KO mice was associated with worsened
myocardial function after CASP compared to WT mice. The detrimental effects of NOS3-
deficiency on myocardial function appear to be caused by impaired Ca2+ handling of
isolated cardiomyocytes obtained from mice subjected to CASP. Depressed Ca2+ handling
of cardiomyocytes of NOS3KO mice were associated with impairment of mitochondrial
integrity and marked depression of the ability of mitochondria to produced ATP, a
determinant of the function of the SR Ca2+-ATPase pump. Taken together, these
observations suggest that endogenous level of NOS3 confer protection against polymicrobial
sepsis-induced inflammation and myocardial dysfunction.
Generalized endothelial dysfunction, with exaggerated coagulation and inflammation, is a
hallmark of severe sepsis and septic shock. Since NO has been shown to inhibit activation of
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platelets and neutrophils (14, 15), role of NOS3 in sepsis has been intensively studied.
Although the use of genetically-modified mouse models greatly advanced our understanding
of the impact of NOS3 in sepsis, majority of the studies have been done in murine endotoxin
challenge models. Endotoxin, the lipopolysaccharide (LPS) associated with outer membrane
of Gram-negative microorganisms, is a homogeneous bacterial product that triggers
inflammatory reaction in a dose-dependent and reproducible manner (16). However, the
overall response to polymicrobial infection, such as that caused by ruptured bowel and
trauma, is far more complex than the effects of LPS alone, raising the question of the
validity of murine LPS challenge as a model of human sepsis (17). In fact, majority of the
results obtained from mouse LPS challenge models were not reproduced in human clinical
trials (18).
In the current study, we therefore opted to use the colon ascendens stent peritonitis (CASP)
model. Polymicrobial (Gram-positive and Gram-negative) fecal peritonitis induced by
CASP closely mimics the clinical course of diffuse peritonitis with early and steadily
increasing systemic infection and inflammation (10). We chose the CASP model over
another peritonitis model, cecum ligation and perforation (CLP), because the former model
has been shown to cause more severe diffuse peritonitis in a more reproducible manner than
CLP (19). We found CASP induced inflammatory cytokine expression in the heart, liver,
and lung in mice. In the heart, inflammatory cytokine expression increased in a time-
dependent manner over 22hr after CASP. NOS3 deficiency markedly enhanced the pro-
inflammatory cytokine induction after CASP. The pro-inflammatory effects of NOS3
deficiency were confirmed by the increased leukocyte infiltration in the liver and heart of
NOS3KO, but not in WT mice, 22h after CASP. These results show that endogenous levels
of NOS3 confer anti-inflammatory effects in a clinically-relevant polymicrobial model of
sepsis.
Interestingly, NOS2 gene expression was markedly increased in the liver and lung 10h after
CASP and it was further enhanced by NOS3 deficiency. These results contradict with the
reports of Connelly and colleagues who demonstrated that LPS-induced NOS2 protein
expression in the liver, lung, heart, and aorta was attenuated by NOS3 deficiency (6).
Reasons for this discrepancy are unknown but likely to be multifactorial. For example, time
courses of cytokine induction after bolus administration of LPS and peritonitis-induced
sepsis are different; the former induces cytokines much earlier than the latter (19). It is
possible that NO derived from NOS3 may have pro-inflammatory effects early after the
onset of endotoxemia while exert anti-inflammatory impact in late phases of sepsis. It is also
conceivable that NO derived from NOS3 plays different roles in infectious process caused
by Gram-negative vs Gram-positive bacteria. A recent human study suggested that a loss-of-
function NOS3 polymorphism (G→T, Glu298Asp) has differing hemodynamic effects
during Gram-negative and Gram-positive bacteremia (20).
Pro-inflammatory cytokines including IL-1β have been implicated as cardio-depressants
responsible for septic cardiomyopathy, and their plasma levels correlate with patient
survival during sepsis (21). The enhanced pro-inflammatory cytokine expression in the heart
of NOS3KO mice in response to polymicrobial infection is likely to be one of the
mechanisms that contribute to the depressed myocardial function and shortened survival
time in NOS3KO mice after CASP. Although precise mechanisms by which cytokines
depress myocardial function during sepsis remain incompletely understood, a number of
hypothesis have been proposed including impaired Ca2+ cycling (i.e., depressed Ca2+ release
and uptake) (22), decreased myofilament sensitivity to Ca2+ (23), and decreased ATP
production by mitochondria (24). In the current study, we found parallel reductions of Ca2+
transient amplitude and sarcomere length change in isolated cardiomyocytes of both
genotypes after CASP, but the magnitudes of reduction in both parameters were greater in
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NOS3KO than in WT cardiomyocytes (see Figure 4F). These observations suggest that
deleterious effects of NOS3 deficiency on cardiomyocyte contraction during sepsis are
primarily caused by more marked impairment of Ca2+ cycling, but not by a greater
depression in myofilament sensitivity to Ca2+.
The SR Ca2+-ATPase is the central regulator of Ca2+ cycling in cardiomyocytes. Although
we found that NOS3 deficiency does not affect the phosphorylation of PLN and SR Ca2+-
ATPase protein levels in cardiac tissue extracts after CASP, SR Ca2+-ATPase activity can
be modulated by multiple factors including local energy state (i.e., ATP supply/demand
balance)(25). In fact, energy deficiency caused by reduced mitochondrial content has been
shown to play a significant role in the pathogenesis of cardiac dysfunction (26). To elucidate
the mechanism responsible for the depressed cardiomyocyte function in NOS3KO after
CASP, we therefore examined the impact of NOS3 on cardiac mitochondorial integrity and
function.
Mitochondrial permeability transition has been implicated as a cause of organ dysfunction
and cell death in sepsis (27). The current study demonstrates that marked cardiac
dysfunction in NOS3KO mice after CASP is associated with an accelerated MPT. These
observations are in line with the findings of Larche and colleagues who showed that sepsis-
induced cardiac dysfunction was associated with accelerated MPT, and inhibition of MPT
with cyclosporine A improved cardiac function after sepsis (28). The loss of mitochondrial
integrity demonstrated as accelerated MPT in septic NOS3KO mice is also consistent with
the markedly reduced ability of NOS3-deficient mitochondria to produced ATP after CASP.
It is conceivable that the impairment of mitochondrial integrity and function depressed local
ATP supply leading to impair the Ca2+ cycling function of the SR Ca2+-ATPase in NOS3-
deficient cardiomyocytes.
The decreased ability to produce ATP in NOS3KO mice was at least in part attributable to
depressed complex I but not complex IV activity in the current study. Mitochondrial
respiratory chain complexes can be inhibited by reactive oxygen species (ROS) and/or
reactive nitrogen species (RNS) (29). Although NO can directly or indirectly inhibit
complex I, NO derived from NOS1 or NOS2 is unlikely to be the primary cause of the
greater inhibition of complex I activity in NOS3KO than in WT mice after CASP; CASP did
not affect cardiac NOS1 and NOS2 expression (see Figure 2) and nitrate/nitrite levels in the
heart were similar in both genotypes after CASP (data not shown). Alternatively, it is
possible that CASP induced higher levels of ROS in the hearts of NOS3KO than in WT,
leading to a greater inhibition of complex I activity (30). Damaged mitochondria in
NOS3KO hearts, as evidenced by an accelerated MPT, is a possible source of increased
ROS production after CASP. In addition, the increased number of leukocytes in the
NOS3KO hearts after CASP is likely to be another source of increased ROS production.
How does NOS3 protect heart during sepsis? NOS3 primarily resides in the plasmalemmal
caveolae in the vicinity of SR-T-tubule junction and modulates functions of plasmalemmal
ion channels (e.g., L-type Ca2+ channel) and SR calcium channels (e.g., ryanodine receptor)
by protein S-nitrosylation (31). Inflammation and ROS are thought to depress myocardial
contractility by causing oxidative modifications of ion channels of cardiomyocytes (32). It is
tempting to speculate that S-nitrosylation induced by NOS3 protects ion channels from the
harmful oxidative modifications. Alternatively, while it is controversial, NOS3 has been
suggested as a candidate for mitochondrial NOS (33). It is possible that NOS3 plays
important role in regulating MPT and ROS production in mitochondria. The molecular
mechanisms responsible for the protective effects of NOS3 on cardiomyocyte function
during sepsis remains to be determined.
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One limitation in the current study is that we measured mitochondrial functions in isolated
mitochondria. The differential centrifugation technique only isolates mitochondria of known
density and size (34). Mitochondria damaged and swollen during the inflammatory process
in sepsis might be largely excluded, leaving only relatively normal mitochondria. Therefore,
our measurements are likely to underestimate the CASP-induced mitochondrial dysfunction.
In addition, several studies have demonstrated that NOS3 deficiency reduces mitochondrial
mass in the heart tissue (35). This implicates that a similar degree of mitochondrial
dysfunction could have a greater impact on myocardial dysfunction in NOS3KO than in WT
mice. These factors may partly explain that the observed difference between genotypes in
CASP-induced mitochondrial dysfunction was relatively small compared with that in
isolated cell functions or hemodynamic study in vivo.
In summary, the current study demonstrates NOS3 deficiency aggravates sepsis-induced
systemic inflammation and myocardial dysfunction in murine polymicrobial sepsis. NOS3
deficiency worsens Ca2+ handling of cardiomyocytes after sepsis and that is associated with
depressed mitochondrial ATP production in the heart. These results demonstrate a protective
role for NOS3 in clinically-relevant polymicrobial sepsis, and implicate that the selective
modulation of NOS3 function could be a therapeutic target for prevention of sepsis-induced
systemic inflammation, myocardial dysfunction, and death.
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Figure 1.
Relative gene expression levels in the liver (A) and lung (B) tissue from WT and NOS3KO
mice at baseline and 10 h after CASP operation. Gene expression was normalized to 18S
rRNA expression level and the mean values for baseline WT mice were set to 1. TNFα,
tumor necrosis factor α; IL-1β, interleukin 1β; IL-6, interleukin 6; ICAM-1, intercellular
adhesion molecule 1; NOS2, nitric oxide synthase 2. N = 3 – 6 for each group. *P<0.05 vs
baseline mice of the same genotype, **P<0.01 vs baseline mice of the same genotype,
#P<0.05 vs WT mice after CASP.
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Figure 2.
Relative gene expression levels in cardiac tissue from WT and NOS3KO mice at baseline
and 10 and 22 h after CASP. Gene expression was normalized to 18S rRNA expression level
and the mean values for baseline WT mice were set to 1. A: TNFα, tumor necrosis factor α,
B: IL-1β, interleukin 1β, C: IL-6, interleukin 6, D: ICAM-1, intercellular adhesion molecule
1, E: NOS1, nitric oxide synthase 1, F: NOS2, nitric oxide synthase 2. N = 4 – 8 for each
group. *P<0.05 vs baseline mice of the same genotype, **P<0.01 vs baseline mice of the
same genotype, #P<0.05 vs WT mice after CASP.
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Figure 3.
Number of CD45+ cells accumulating in the liver or heart at baseline and 22h after CASP in
WT (open bar) and NOS3KO (black bar) mice. *P<0.05 vs same genotype at baseline.
#P<0.05 vs WT mice after CASP.
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Figure 4.
Contractility and Ca2+ handling of isolated cardiomyocytes 22h after CASP. A:
Representative tracings of changes in sarcomere length (SL) and intracellular Ca2+
transients ([Ca2+]i) of isolated cardiomyocytes paced at 2 Hz. B–E: Effects of CASP on the
contractile function and Ca2+ handling of isolated cardiomyocytes paced at 2 Hz. Data were
summarized for peak percent SL shortening (B), peak amplitude of [Ca2+]i (Δ[Ca2+]i) (C),
the time constant for SL relengthening (D) and the time constant for [Ca2+]i decay (E). 20–
25 cells from 3 – 5 mice were analyzed for each group. *P<0.05 vs cardiomyocytes from
control mice of the same genotype, #P<0.05 vs cardiomyocytes from WT mice after CASP.
F: Effects of CASP on relationship of peak systolic [Ca2+] and %SL shortening.
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Figure 5.
Immunoblot analysis. Protein expression of SR Ca2+-ATPase2a (A), fractions of
phospholamban phosphorylated at Ser16 (PLN Ser16 (B)) or Thr17 (PLN Thr17 (C)) in
cardiac tissue extracts from WT and NOS3KO mice 22 h after CASP or sham operation are
shown with loading control (β-tubulin). Data were normalized to WT sham groups.
Representative blots from 2 – 4 mice for each group are shown. N = 6 – 8 for each group.
Bougaki et al. Page 17
Shock. Author manuscript; available in PMC 2013 September 16.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 6.
Measurements of Mitochondrial Permeability Transition (MPT) in isolated mitochondria
22h after CASP or sham operation. A: Representative tracings of absorbance change.
Absorbance values at the beginning and the end of measurement were set to 1 and 0,
respectively. B: Effects of CASP on the time to one-half of the absorbance change (t1/2) in
WT and NOS3KO after CASP or sham operation. N = 9 – 10 for each group. *P<0.05 vs
NOS3KO after sham operation.
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Figure 7.
Inhibition of oxidative phosphorylation in cardiac mitochondria after CASP. A: ATP
production ability in cardiac mitochondria 22 h after CASP or sham operation. N = 7 – 9 for
CASP groups and N = 3 for sham groups. B and C: Respiratory chain enzyme activities
(complex I (B) and complex IV (C)) in cardiac mitochondria 22 h after CASP or sham
operation. N= 5 – 7 for each group. *P<0.05 vs WT after sham operation, **P<0.01 vs
NOS3KO after sham operation, #P<0.05 vs WT after CASP.
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Table 1
Sepsis score
Parameter Criteria scores
Appearance ▪normal, smooth fur 0
▪roughened fur 1
▪wet fur 2
▪mucous eyes 3
Breathing pattern ▪normal 0
▪fast 1
▪slow 2
▪weak and intermittent 3
Weight change ▪−5% 0
▪−15% 1
▪−20 % 2
▪> −20% 3
Behavior ▪normal, agile, prying 0
▪slow movements, sitting position 1
▪dull, slouched, tottering movements 2
▪lateral position 3
Provoked reaction ▪escape reaction when cage is opened 0
▪flight when approached by hand 1
▪flight when touched 2
▪no flight reaction at all 3
Shock. Author manuscript; available in PMC 2013 September 16.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Bougaki et al. Page 21
Table 2
Hemodynamic measurements 22h after CASP or sham operation
WT NOS3KO
n sham
5
CASP
8
sham
6
CASP
7
HR, bpm 567±11 567±11 538±13 547±21
LVESP, mmHg 111±4 77±6 131±6# 84±10*
LVEDP, mmHg 2±0 5±1 3±0 8±2*#
dP/dtmax, mmHg/s 19768±1084 11667±1726* 17637±369 6527±795*#
dP/dtmin, mmHg/s −9974±875 −9809±1071 −11363±1505
−5013±728*#
EF, % 61±4 45±3* 69±4 34±4*#
CO, ml/min 14.8±1.6 17.5±1.8 13.5±2.1 8.1±1.3*#
dP/dtmax/IP, s−1 222±8 219±8 201±15 135±21*#
Ea, mmHg/μL 3±2 3±1 5±1 6±1#
Ees, mmHg/μL 27±6 16±3 30±6 10±1*
Ea/Ees 0.1±0.1 0.2±0.1 0.2±0.1 0.6±0.1*#
τ, msec 5.5±0.2 4.6±0.2 5.5±0.1 8.5±1.2*#
Values are means ± SE. HR, heart rate; LVESP, left ventricular end-systolic pressure; LVEDP, left ventricular end-diastolic pressure; dP/dtmax,
maximum rate of developed left ventricular pressure; dP/dtmin, minimum rate of developed left ventricular pressure; EF, ejection fraction; CO,
cardiac output; dP/dtmax/IP, dP/dtmax divided by instantaneous pressure; Ea, arterial elastance; Ees, left ventricular end-systolic elastance; Ea/
Ees, ratio of Ea to Ees; τ, time constant of isovolumic relaxation.
*
P<0.05 vs sham-operated mice of the same genotype.
#
P<0.05 vs WT mice with the same operation.
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